Current medicinal chemistry. Cardiovascular and hematological agents
about
Aspirin and clopidogrel: a sweeping combination in cardiologySnake venom metalloproteinase containing a disintegrin-like domain, its structure-activity relationships at interacting with integrinsTargeting the renin-angiotensin system: what's new?Non-peptidic small-molecule antagonists of the human platelet thrombin receptor PAR-1.Urocortins: putative role in cardiovascular disease.Peptide-derived protease-activated receptor-1 (PAR-1) antagonists.The pharmacologic approach to the prevention of preeclampsia: from antiplatelet, antithrombosis and antioxidant therapy to anticonvulsants.Platelet glycoprotein IIb/IIIa inhibition and its clinical use.Thrombocytopenia in HIV disease: clinical relevance, physiopathology and management.The adipose tissue as a source of vasoactive factors.Designing of novel carbonic anhydrase inhibitors and activators.Discovery of potent peptide-mimetic antagonists for the human thrombin receptor, protease-activated receptor-1 (PAR-1).Potent non-peptide thrombin receptor antagonists.Proteinase-activated receptor-2: physiological and pathophysiological roles.Protease-activated receptor-2 antagonists and agonists.Bone marrow reconstitution as a relevant model of genetically programmed leukemia.1-Azaadamantanes: pharmacological applications and synthetic approaches.New advances in the field of calcium channel antagonists: cardiovascular effects and structure-activity relationships.Structure-activity relationships of snake toxins targeting platelet receptors, glycoprotein Ib-IX-V and glycoprotein VI.Diadenosine polyphosphates: postulated mechanisms mediating the cardiac effects.Development of peptide inhibitors to block type I and type III collagen-platelet interaction.Capsaicin sensitive-sensory nerves and blood pressure regulation.Modulation of integrin-binding selectivity by mutation within the RGD-loop of snake venom proteins: a novel drug development approach.Urocortins: take them to heart.Efficacy of enzyme replacement therapy in Fabry disease.Mineralocorticoid receptor antagonism and cardiac remodeling in ischemic heart failure.Emerging technologies in biocompatible surface modifying additives: quest for physiologic cardiopulmonary bypass.Alpha2-antiplasmin: potential therapeutic roles in fibrin survival and removal.Novel antithrombotic agents: indirect synthetic inhibitors of factor Xa and direct thrombin inhibitors. Evidences from clinical studies.Atherosclerosis -- new targets and therapeutics.Salutary properties of YC-1 in the cardiovascular and hematological systems.Catalytic features, regulation and function of myocardial phospholipase A2.Peptide metabolism and the control of body fluid homeostasis.Novel human plasma proteins, IHRP (acute phase protein) and PHBP (serine protease), which bind to glycosaminoglycans.Preconditioning of the myocardium by volatile anesthetics.New insights into the intracellular mechanisms by which PGI2 analogues elicit vascular relaxation: cyclic AMP-independent, Gs-protein mediated-activation of MaxiK channel.Direct antithrombins: new perspectives in cardiovascular medicine.Vascular effects of antiarrhythmic drugs and the roles of K+ channels.Drug targeting of estrogen receptor signaling in the cardiovascular system: preclinical and clinical studies.L-Arginine transport in disease.
P1433
Q28181565-0D4670E7-CEDD-4E84-99D6-A8F78F7A479AQ28258075-923A4493-6F4C-42F5-9426-B1ADA226AC75Q28645957-02B91CF5-6486-4F40-B245-6FE0ABE37EECQ30952681-40493E07-4019-4A7D-8C36-C6892412FD91Q30952923-BB87DC37-46B5-4EC1-98A6-A1F0FFCF7465Q31106620-9138C791-36CB-42DD-A3C4-5942325E4A82Q33217746-C4281361-D282-4BDD-8086-DFAE48ECD7A1Q33362200-E4FA1405-CD8A-4587-9A0A-B7447D342E45Q33369064-70766AA2-CB28-4230-A8B0-1BAEA8BBD1D5Q34342326-C372980F-BB25-4F68-A2C9-0EB4528464ACQ34343296-38DE85AC-E92C-4994-91C0-7E656416F37FQ35865999-9A4E1C98-6599-410C-863C-FAFC56754A23Q35866004-DBC587D4-7818-436F-8AD8-87E5C8592843Q35866007-BCA7126B-E7E3-453E-AA13-119FBD9C1830Q35866011-FC1B2C7F-0455-4D2A-9E40-433E14C3FFA3Q35867051-B89BD060-02C6-483F-921C-EEE8936AA0A7Q35867054-955D034C-5D23-496B-8D83-8A05F7162984Q35867058-00207F31-C3F3-4324-8962-C1E0E60BD6ADQ35867062-CCB5F559-B778-4A3B-BD1A-0E6D5BD85DFBQ35867066-809E0E00-E2B5-4A2F-BEE4-10279E6556F3Q35867070-8BEC14F0-55CD-4CB0-8964-1393B615F155Q35867074-55DEC660-3FF4-4A6E-A5C7-47E84921C944Q35867079-32E20088-A8CA-4F59-A82D-342A9316C750Q35867298-A8A06B81-7445-40DF-BAB8-3ABCEEF9683CQ35867301-838438A1-BA67-44AF-BB7B-8FEB50722316Q35867304-833DFBB4-6C55-42ED-8AFF-210FA730E4E8Q35867308-BF9F159A-C060-47B0-B3E1-0EFC3E9ADE4AQ35867311-C44C1D98-17DE-4127-A68A-EEA82D24FE82Q35867315-A83FBFB0-9C80-4DCF-BEDB-7BE2241F62E6Q35867319-78FEF2CD-7B44-4D5B-BF52-49E828410724Q35867325-46B338F3-92E5-4273-BAE7-DC83BFFD4136Q35867329-8807441C-FF06-4696-BC80-15454CB5B066Q35867333-3A102B31-FC40-46E5-B430-FEFDFC981C69Q35867337-722DFEA6-1825-41E3-9E96-ED59F260170AQ35867341-093E95AE-D956-4210-BD78-A62370AA3DDBQ35867345-C1435402-0CF5-4825-BEE3-062A168767D3Q35867349-0201081B-8597-4CC5-B512-FF4CB6F674F3Q35867354-FD80EF0E-D092-4DC0-A7B2-A97E8205E14FQ35867358-B954707B-D0D9-41BA-AFB4-B2799A3CBEA8Q35867363-62F11DCA-3E48-49F3-9E85-6D5926C70B88
P1433
Current medicinal chemistry. Cardiovascular and hematological agents
description
journal
@en
revista científica
@es
wetenschappelijk tijdschrift van Bentham Science Publishers
@nl
wissenschaftliche Fachzeitschrift
@de
name
Current medicinal chemistry. Cardiovascular and hematological agents
@ast
Current medicinal chemistry. Cardiovascular and hematological agents
@en
Current medicinal chemistry. Cardiovascular and hematological agents
@es
Current medicinal chemistry. Cardiovascular and hematological agents
@nl
type
label
Current medicinal chemistry. Cardiovascular and hematological agents
@ast
Current medicinal chemistry. Cardiovascular and hematological agents
@en
Current medicinal chemistry. Cardiovascular and hematological agents
@es
Current medicinal chemistry. Cardiovascular and hematological agents
@nl
altLabel
Curr Med Chem Cardiovasc Hematol Agents
@en
prefLabel
Current medicinal chemistry. Cardiovascular and hematological agents
@ast
Current medicinal chemistry. Cardiovascular and hematological agents
@en
Current medicinal chemistry. Cardiovascular and hematological agents
@es
Current medicinal chemistry. Cardiovascular and hematological agents
@nl
P3181
P1055
P1156
P1476
Current medicinal chemistry. Cardiovascular and hematological agents
@en